HYPOPLASTIC MDS

Clinical trials for HYPOPLASTIC MDS explained in plain language.

Never miss a new study

Get alerted when new HYPOPLASTIC MDS trials appear

Sign up with your email to follow new studies for HYPOPLASTIC MDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for rare bone marrow diseases: drug tames immune attack

Disease control Ongoing

This study tests a pill called ruxolitinib for people whose immune system attacks their bone marrow, causing conditions like severe anemia. The drug aims to stop this attack and help the bone marrow recover. Participants take the pill twice daily for up to 6 months and are follow…

Matched conditions: HYPOPLASTIC MDS

Phase: PHASE1, PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated Jul 17, 2026 00:00 UTC

HYPOPLASTIC MDS

Get alerted when new HYPOPLASTIC MDS trials appear

New hope for rare bone marrow diseases: drug tames immune attack